MyD88-deficient mice exhibit decreased parasite-induced immune responses but reduced disease severity in a murine model of neurocysticercosis

Infection and Immunity

Volumn 77, Issue 12, 2009, Pages 5369-5379

  Mishra, Bibhuti B ^a   Gundra, Uma Mahesh ^a   Wong, Kondi ^b   Teale, Judy M ^a  

^a UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

^b TAMPA GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; FIBRINOGEN; GAMMA INTERFERON; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOID DIFFERENTIATION FACTOR 88; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BLOOD BRAIN BARRIER; BONE MARROW CELL; CELL DIFFERENTIATION; CELL INFILTRATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DISEASE SEVERITY; EXTRAVASATION; FEMALE; GLIOSIS; HISTOPATHOLOGY; IMMUNE RESPONSE; INOCULATION; MEMBRANE PERMEABILITY; MESOCESTOIDEA; MESOCESTOIDES CORTI; MICROGLIOSIS; MOUSE; NEUROCYSTICERCOSIS; NEUROPATHOLOGY; NONHUMAN; PARASITE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL; T LYMPHOCYTE; TISSUE INJURY;

ANIMALS; B-LYMPHOCYTES; BRAIN; CYTOKINES; FEMALE; MESOCESTOIDES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOID CELLS; MYELOID DIFFERENTIATION FACTOR 88; NEUROCYSTICERCOSIS; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; T-LYMPHOCYTES;

EID: 72449208006     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00455-09     Document Type: Article

References (58)

1. Abbott, N. 2002. Astrocyte-endothelial interactions and blood-brain barrier permeability. J. Anat. 200:527.
2. Adachi, O., T. Kawai, K. Takeda, M. Matsumoto, H. Tsutsui, M. Sakagami, K. Nakanishi, and S. Akira. 1998. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9:143-150. (Pubitemid 28361303)
3. Alvarez, J. I., J. Rivera, and J. M. Teale. 2008. Differential release and phagocytosis of tegument glycoconjugates in neurocysticercosis: implications for immune evasion strategies. PLoS Negl. Trop. Dis. 2:e218.
4. Alvarez, J. I., and J. M. Teale. 2006. Breakdown of the blood brain barrier and blood-cerebrospinal fluid barrier is associated with differential leukocyte migration in distinct compartments of the CNS during the course of murine NCC. J. Neuroimmunol. 173:45-55.
5. Alvarez, J. I., and J. M. Teale. 2007. Differential changes in junctional complex proteins suggest the ependymal lining as the main source of leukocyte infiltration into ventricles in murine neurocysticercosis. J. Neuroimmunol. 187:102-113.
6. Alvarez, J. I., and J. M. Teale. 2007. Evidence for differential changes of junctional complex proteins in murine neurocysticercosis dependent upon CNS vasculature. Brain Res. 1169:98-111.
7. Alvarez, J. I., and J. M. Teale. 2008. Multiple expression of matrix metalloproteinases in murine neurocysticercosis: implications for leukocyte migration through multiple central nervous system barriers. Brain Res. 1214:145-158.
8. Bafica, A., H. C. Santiago, R. Goldszmid, C. Ropert, R. T. Gazzinelli, and A. Sher. 2006. Cutting edge: TLR9 and TLR2 signaling together account for MyD88-dependent control of parasitemia in Trypanosoma cruzi infection. J. Immunol. 177:3515-3519. (Pubitemid 44359881)
9. Bates, D. O., N. J. Hillman, B. Williams, C. R. Neal, and T. M. Pocock. 2002. Regulation of microvascular permeability by vascular endothelial growth factors. J. Anat. 200:581-597. (Pubitemid 34823050)
10. Boraschi, D., and A. Tagliabue. 2006. The interleukin-1 receptor family. Vitam. Horm. 74:229-254.
11. Brett, F. M., A. P. Mizisin, H. C. Powell, and I. L. Campbell. 1995. Evolution of neuropathologic abnormalities associated with blood-brain barrier breakdown in transgenic mice expressing interleukin-6 in astrocytes. J. Neuropathol. Exp. Neurol. 54:766-775.
12. Brooks, T. A., B. T. Hawkins, J. D. Huber, R. D. Egleton, and T. P. Davis. 2005. Chronic inflammatory pain leads to increased blood-brain barrier permeability and tight junction protein alterations. Am. J. Physiol. Heart Circ. Physiol. 289:H738-H743.
13. Cardona, A. E., P. A. Gonzalez, and J. M. Teale. 2003. CC chemokines mediate leukocyte trafficking into the central nervous system during murine neurocysticercosis: role of gamma delta T cells in amplification of the host immune response. Infect. Immun. 71:2634-2642.
14. Cardona, A. E., B. I. Restrepo, J. M. Jaramillo, and J. M. Teale. 1999. Development of an animal model for neurocysticercosis: immune response in the central nervous system is characterized by a predominance of gamma delta T cells. J. Immunol. 162:995-1002.
15. Cardona, A. E., and J. M. Teale. 2002. Gamma/delta T cell-deficient mice exhibit reduced disease severity and decreased inflammatory response in the brain in murine neurocysticercosis. J. Immunol. 169:3163-3171.
16. Chavarria, A., and J. Alcocer-Varela. 2004. Is damage in central nervous system due to inflammation? Autoimmun. Rev. 3:251-260.
17. Coban, C., K. J. Ishii, S. Uematsu, N. Arisue, S. Sato, M. Yamamoto, T. Kawai, O. Takeuchi, H. Hisaeda, T. Horii, and S. Akira. 2007. Pathological role of Toll-like receptor signaling in cerebral malaria. Int. Immunol. 19:67-79.
18. Fremond, C. M., V. Yeremeev, D. M. Nicolle, M. Jacobs, V. F. Quesniaux, and B. Ryffel. 2004. Fatal Mycobacterium tuberculosis infection despite adaptive immune response in the absence of MyD88. J. Clin. Investig. 114:1790-1799.
19. Garcia, H. H., and O. H. Del Brutto. 2005. Neurocysticercosis: updated concepts about an old disease. Lancet Neurol. 4:653-661.
20. Hall, L. R., and E. Pearlman. 1999. Pathogenesis of onchocercal keratitis (river blindness). Clin. Microbiol. Rev. 12:445-453.
21. Hawkins, B. T., and T. P. Davis. 2005. The blood-brain barrier/neurovascular unit in health and disease. Pharmacol. Rev. 57:173-185.
22. Hise, A. G., K. Daehnel, I. Gillette-Ferguson, E. Cho, H. F. McGarry, M. J. Taylor, D. T. Golenbock, K. A. Fitzgerald, J. W. Kazura, and E. Pearlman. 2007. Innate immune responses to endosymbiotic Wolbachia bacteria in Brugia malayi and Onchocerca volvulus are dependent on TLR2, TLR6, MyD88, and Mal, but not TLR4, TRIF, or TRAM. J. Immunol. 178:1068-1076.
23. Honda, K., H. Yanai, T. Mizutani, H. Negishi, N. Shimada, N. Suzuki, Y. Ohba, A. Takaoka, W. C. Yeh, and T. Taniguchi. 2004. Role of a transductional- transcriptional processor complex involving MyD88 and IRF-7 in Toll-like receptor signaling. Proc. Natl. Acad. Sci. USA 101:15416-15421.
24. Irani, D. N., and D. E. Griffin. 1991. Isolation of brain parenchymal lymphocytes for flow cytometric analysis. Application to acute viral encephalitis. J. Immunol. Methods 139:223-231.
25. Johnson, A., and E. Pearlman. 2005. Toll-like receptors in the cornea. Ocul. Surf. 3:S187-S189.
26. Johnson, A. C., F. P. Heinzel, E. Diaconu, Y. Sun, A. G. Hise, D. Golenbock, J. H. Lass, and E. Pearlman. 2005. Activation of Toll-like receptor (TLR)2, TLR4, and TLR9 in the mammalian cornea induces MyD88-dependent corneal inflammation. Investig. Ophthalmol. Vis. Sci. 46:589-595.
27. Kluver, H., and E. Barrera. 1953. A method for the combined staining of cells and fibers in the nervous system. J. Neuropathol. Exp. Neurol. 12:400-403.
28. McDermott, E. P., and L. A. O'Neill. 2002. Ras participates in the activation of p38 MAPK by interleukin-1 by associating with IRAK, IRAK2, TRAF6, and TAK-1. J. Biol. Chem. 277:7808-7815.
29. Mishra, B. B., U. M. Gundra, and J. M. Teale. 2008. Expression and distribution of Toll-like receptors 11-13 in the brain during murine neurocysticercosis. J. Neuroinflamm. 5:53.
30. Mishra, B. B., P. K. Mishra, and J. M. Teale. 2006. Expression and distribution of Toll-like receptors in the brain during murine neurocysticercosis. J. Neuroimmunol. 181:46-56.
31. Mitchell, J. A., M. J. Paul-Clark, G. W. Clarke, S. K. McMaster, and N. Cartwright. 2007. Critical role of Toll-like receptors and nucleotide oligomerisation domain in the regulation of health and disease. J. Endocrinol. 193:323-330.
32. Nash, T. E., G. Singh, A. C. White, V. Rajshekhar, J. A. Loeb, J. V. Proano, O. M. Takayanagui, A. E. Gonzalez, J. A. Butman, C. DeGiorgio, O. H. Del Brutto, A. Delgado-Escueta, C. A. Evans, R. H. Gilman, S. M. Martinez, M. T. Medina, E. J. Pretell, J. Teale, and H. H. Garcia. 2006. Treatment of neurocysticercosis: current status and future research needs. Neurology 67:1120-1127.
33. Negishi, H., Y. Fujita, H. Yanai, S. Sakaguchi, X. Ouyang, M. Shinohara, H. Takayanagi, Y. Ohba, T. Taniguchi, and K. Honda. 2006. Evidence for licensing of IFN-gamma-induced IFN regulatory factor 1 transcription factor by MyD88 in Toll-like receptor-dependent gene induction program. Proc. Natl. Acad. Sci. USA 103:15136-15141.
34. Ojaniemi, M., V. Glumoff, K. Harju, M. Liljeroos, K. Vuori, and M. Hallman. 2003. Phosphatidylinositol 3-kinase is involved in Toll-like receptor 4-mediated cytokine expression in mouse macrophages. Eur. J. Immunol. 33:597-605.
35. O'Neill, L. A., and A. G. Bowie. 2007. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat. Rev. Immunol. 7:353-364.
36. Otto, V. I., S. M. Gloor, S. Frentzel, U. Gilli, E. Ammann, A. E. Hein, G. Folkers, O. Trentz, T. Kossmann, and M. C. Morganti-Kossmann. 2002. The production of macrophage inflammatory protein-2 induced by soluble intercellular adhesion molecule-1 in mouse astrocytes is mediated by Src tyrosine kinases and p42/44 mitogen-activated protein kinase. J. Neurochem. 80:824-834.
37. Rakoff-Nahoum, S., and R. Medzhitov. 2009. Toll-like receptors and cancer. Nat. Rev. Cancer 9:57-63.
38. Restrepo, B. I., J. I. Alvarez, J. A. Castano, L. F. Arias, M. Restrepo, J. Trujillo, C. H. Colegial, and J. M. Teale. 2001. Brain granulomas in neurocysticercosis patients are associated with a Th1 and Th2 profile. Infect. Immun. 69:4554-4560.
39. Restrepo, B. I., P. Llaguno, M. A. Sandoval, J. A. Enciso, and J. M. Teale. 1998. Analysis of immune lesions in neurocysticercosis patients: central nervous system response to helminth appears Th1-like instead of Th2. J. Neuroimmunol. 89:64-72.
40. Risau, W., and H. Wolburg. 1990. Development of the blood-brain barrier. Trends Neurosci. 13:174-178.
41. Robinson, P., R. L. Atmar, D. E. Lewis, and A. C. White, Jr. 1997. Granuloma cytokines in murine cysticercosis. Infect. Immun. 65:2925-2931.
42. Rock, F. L., G. Hardiman, J. C. Timans, R. A. Kastelein, and J. F. Bazan. 1998. A family of human receptors structurally related to Drosophila Toll. Proc. Natl. Acad. Sci. USA 95:588-593.
43. Roman, G., J. Sotelo, O. Del Brutto, A. Flisser, M. Dumas, N. Wadia, D. Botero, M. Cruz, H. Garcia, P. R. de Bittencourt, L. Trelles, C. Arriagada, P. Lorenzana, T. E. Nash, and A. Spina-Franca. 2000. A proposal to declare neurocysticercosis an international reportable disease. Bull. W. H. O. 78:399-406.
44. Ropert, C., B. S. Franklin, and R. T. Gazzinelli. 2008. Role of TLRs/MyD88 in host resistance and pathogenesis during protozoan infection: lessons from malaria. Semin. Immunopathol. 30:41-51.
45. Scanga, C. A., J. Aliberti, D. Jankovic, F. Tilloy, S. Bennouna, E. Y. Denkers, R. Medzhitov, and A. Sher. 2002. Cutting edge: MyD88 is required for resistance to Toxoplasma gondii infection and regulates parasite-induced IL-12 production by dendritic cells. J. Immunol. 168:5997-6001.
46. Schnare, M., M. Rollinghoff, and S. Qureshi. 2006. Toll-like receptors: sentinels of host defence against bacterial infection. Int. Arch. Allergy Immunol. 139:75-85.
47. Sun, D., and A. Ding. 2006. MyD88-mediated stabilization of interferon-gamma- induced cytokine and chemokine mRNA. Nat. Immunol. 7:375-381.
48. Takaoka A. Yanai H. Kondo S. Duncan G. Negishi H. Mizutani T. Kano S.-I. Honda K. Ohba Y. Mak T.W. Taniguchi T. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors Nature 2005 434 7030 243-249 DOI 10.1038/nature03308 48. Takaoka, A., H. Yanai, S. Kondo, G. Duncan, H. Negishi, T. Mizutani, S. Kano, K. Honda, Y. Ohba, T. W. Mak, and T. Taniguchi. 2005. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature 434:243-249. (Pubitemid 40388058)
49. Takeda K. Evolution and integration of innate immune recognition systems: The Toll-like receptors Journal of Endotoxin Research 2005 11 1 51-55 DOI 10.1179/096805105225006687 49. Takeda, K. 2005. Evolution and integration of innate immune recognition systems: the Toll-like receptors. J. Endotoxin Res. 11:51-55. (Pubitemid 40533080)
50. Takeda, K., and S. Akira. 2005. Toll-like receptors in innate immunity. Int. Immunol. 17:1-14.
51. Takeda, K., T. Kaisho, and S. Akira. 2003. Toll-like receptors. Annu. Rev. Immunol. 21:335-376.
52. Takeuchi O. Hoshino K. Akira S. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection Journal of Immunology 2000 165 10 5392-5396 52. Takeuchi, O., K. Hoshino, and S. Akira. 2000. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J. Immunol. 165:5392-5396. (Pubitemid 30836143)
53. Ulevitch, R. J., J. C. Mathison, and J. da Silva Correia. 2004. Innate immune responses during infection. Vaccine 22(Suppl. 1):S25-S30.
54. West, A. P., A. A. Koblansky, and S. Ghosh. 2006. Recognition and signaling by Toll-like receptors. Annu. Rev. Cell Dev. Biol. 22:409-437.
55. White, A. C. 1997. Neurocysticercosis: a major cause of neurological disease worldwide. Clin. Infect. Dis. 24:101-113.
56. White, A. C. 2000. Neurocysticercosis: updates on epidemiology, pathogenesis, diagnosis, and management. Annu. Rev. Med. 51:187-206. doi:10.1146/ annurev.med.51.1.187.
57. White, A. C., Jr., P. Robinson, and R. Kuhn. 1997. Taenia solium cysticercosis: host-parasite interactions and the immune response. Chem. Immunol. 66:209-230.
58. Yatsiv, I., M. C. Morganti-Kossmann, D. Perez, C. A. Dinarello, D. Novick, M. Rubinstein, V. I. Otto, M. Rancan, T. Kossmann, C. A. Redaelli, O. Trentz, E. Shohami, and P. F. Stahel. 2002. Elevated intracranial IL-18 in humans and mice after traumatic brain injury and evidence of neuroprotective effects of IL-18-binding protein after experimental closed head injury. J. Cereb. Blood Flow Metab. 22:971-978.